Drug Type Small molecule drug |
Synonyms TELMISARTAN/HYDROCHLOROTHIAZIDE, Telmisartan and Hydrochlorothiazide, Telmisartan/Hydrochlorothiazide + [14] |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (17 Nov 2000), |
RegulationPriority Review (CN) |
Molecular FormulaC40H38ClN7O6S2 |
InChIKeyOZCVMXDGSSXWFT-UHFFFAOYSA-N |
CAS Registry485391-74-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | NO | 19 Apr 2002 | |
Essential Hypertension | IS | 19 Apr 2002 | |
Essential Hypertension | EU | 19 Apr 2002 | |
Essential Hypertension | EU | 19 Apr 2002 | |
Essential Hypertension | IS | 19 Apr 2002 | |
Essential Hypertension | LI | 19 Apr 2002 | |
Essential Hypertension | NO | 19 Apr 2002 | |
Essential Hypertension | LI | 19 Apr 2002 | |
Hypertension | US | 17 Nov 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Essential Hypertension | Phase 2 | JP | 01 May 2006 |
Phase 3 | 132 | (Telmisartan + HCTZ + Amlodipine) | smjazvscvt(jahmebkors) = nhggqmrzba lfmurjgawb (mtwwjedrbb, bgtgsjlika - wwuzwpuqqi) View more | - | 28 Mar 2016 | ||
placebo+telmisartan + HCTZ (Telmisartan + HCTZ + Placebo) | smjazvscvt(jahmebkors) = cboonorjys lfmurjgawb (mtwwjedrbb, kkaxieqeae - ewlabdhzpc) View more | ||||||
Phase 3 | - | 639 | xivodwalwo(ijclqntadx) = occurred in 29 (4.5%) patients ufnmvjohpw (casdzmtnqv ) | - | 01 Feb 2009 |